title: [Prevention of neuro- and cardiotoxic side effects of tuberculosis chemotherapy with noopept].
abstract: The study evaluated clinical efficiency of noopept used to prevent adverse side effects of antituberculous agents. It included 60 patients with newly diagnosed respiratory tuberculosis. Those in group 1 (n = 30) received 10 mg of noopept twice daily during the first month. The treatment promoted functional normalization of vegetative nervous system and antioxidative systems, reduced manifestations of anxiety, decreased frequency of adverse neuro- and cardiotoxic responses to antituberculous drugs.
authors: A V
authors: AV
authors: Mordyk
authors: A V
authors: AV
authors: Lysov
authors: A V
authors: AV
authors: Kondria
authors: M A
authors: MA
authors: Gol'dzon
authors: N V
authors: NV
authors: Khlebova
mesh_terms: D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001007:Anxiety / Q000139:chemically induced / Q000188:drug therapy*; D004151:Dipeptides / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000995:Antitubercular Agents; D004151:Dipeptides; C103871:ethyl phenylacetyl-Pro-Gly